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To determine the ultrastructural distribution and immunological accessibility of proteins II (P.IIs) on the
surfaces of whole gonococci, anti-P.II gold probes were developed and used in electron microscopic studies of
viable P.II-expressing variants of Neisseria gonorrhoeae FA1090. Anti-P.II probes clearly marked the surfaces
of organisms and their associated outer membrane blebs. The surface-exposed portion of P.11 is antigenically
variable. With the use of two different sizes of gold probes, it was demonstrated that individual gonococcal cells
can express more than one antigenic type of P.II simultaneously.
The surface proteins of gonococci, which are probably
important in the interaction of the organisms with mucosal
cell surfaces, have been extensively characterized (3, 5, 8,
19). Some of the proteins, such as outer membrane protein II
(P.Il), demonstrate marked interstrain and intrastrain struc-
tural and antigenic diversity (2, 7, 9, 11, 17, 20). Variants of
a single gonococcal strain can express antigenically different
P.1I proteins, and changes in expression of the protein occur
at high frequencies (16, 17). The high rate of P.II switching
results in gonococcal populations that are always heteroge-
neous in P.II expression, and it has been difficult to charac-
terize expression of the proteins in individual organisms.
Recent advances in immunoelectron microscopy using
gold spheres conjugated to specific antibodies allow visual-
ization of the ultrastructural distribution and immunological
accessibility of native antigens on the surfaces of viable
bacteria (12-15). Application of this technique to the study of
gonococcal surface proteins has revealed unexpected heter-
ogeneity in labeling with antibodies specific for protein I and
the common neisserial antigen H.8 (12). These components
are produced by all gonococcal strains tested, but H.8- or
protein I-specific gold probes label only some of the orga-
nisms in a population. A possible explanation for this is that
the antigens are sometimes covered or masked by another
surface component that is variably present, such as P.II. In
this study, we used monoclonal antibodies specific for dif-
ferent P.IIs to determine the distribution and accessibility of
P.11 on the surfaces of whole gonococci and the ability of
single organisms to express more than one P.1I simulta-
neously. We also tested the possibility that changes in the
expression of P.II affect the surface accessibility of the H.8
antigen.
The microorganisms used in this study were P.II-ex-
pressing phenotypes of Neisseria gonorrhoeae FA1090 (10).
FA1090 is a serum-resistant, prototrophic strain originally
isolated from a patient with probable disseminated gono-
coccal infection. Single-colony isolates were passaged on
solid agar and chosen for expression of different molecular
weight and antigenic types of P.II as previously described
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(2). The P.IIs were designated P.IIa through P.IIf in order of
increasing molecular weight, as demonstrated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (2). Cul-
tures with six phenotypes of FA1090, each expressing pre-
dominantly a single P.II, and one phenotype that did not
express any P.II were used.
Cultures with the P.II phenotypes displayed colony mor-
phologies with various degrees of opacity and transparency,
depending on the P.II expressed (18). After 18 to 20 h of
incubation in a 2% CO2 incubator at 37°C, organisms were
harvested from clear agar medium and used in immunoelec-
tron microscopic studies (12).
Culture supernatants containing monoclonal antibodies
specific for strain FA1090 organisms with P.11 phenotypes
were prepared and characterized as previously described
(10). The anti-P.II monoclonal antibody preparations used in
this study have the following designations, with the P.II
specificities given in parentheses: H.138.1 (anti-P.IIa), H.4.1
(anti-P.IIb and anti-P.IId), H.157.1.8 (anti-P.IIc), H.164
(anti-P.IIe), and H.156.2 (anti-P.IIf). Monoclonal anti-H.8
antibody was prepared and characterized as previously
described (6).
Specific monoclonal P.II and H.8 antibodies were individ-
ually conjugated to electron-dense gold spheres, and the
resultant gold probes were used to mark whole gonococci as
previously described in detail (12, 15). All specimens were
examined by transmission electron microscopy (JOEL 100S,
Tokyo, Japan).
Anti-P.II gold probes clearly marked the surfaces of
P.II-expressing gonococci and their associated outer mem-
brane blebs (Fig. 1). However, within each of these highly
select gonococcal variants there were organisms which were
not labeled by the homologous anti-P.II probes (Fig. 2).
When organisms of the P.IIa-expressing phenotype were
exposed to probes directed against the other antigenic types
of P.II, a small percentage (1 to 6%) of the cells was marked
by each of the heterologous immunologic probes. Similarly,
when organisms of the P.II culture were exposed to each of
the anti-P.II probes, a small percentage (1 to 15%) of the
cells was marked. Thus, although most of the cells from
these cultures expressed one antigenic type of P.II predom-
inantly, cultures of gonococcal P.II phenotypes contained
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FIG. 1. Ultrastructural localization of accessible outer membrane protein Ila on the surface of N. gonorrhoeae FA1090 (phenotype P.IIa),
as detected by gold spheres complexed with a P.IIa-specific monoclonal antibody. Note the heavy attachment of gold spheres to the surfaces
of viable organisms and the outer membrane blebs associated with them. Similar labeling of the surfaces of organisms and outer membrane
blebs was seen when other P.11 variants were examined with homologous anti-P.II-specific gold probes. Few organisms of cultures of this
P.IIa-expressing variant were labeled with heterologous anti-P.II gold probes. Thus, the surface-exposed portions of P.IIs, as detected by
anti-P.h1 antibody-gold probes, appear to be highly antigenically variable. Negative stain was used. Magnification, x 36,920.
"contaminating" gonococci expressing different antigenic
types of P.11.
To determine whether a single gonococcal cell is capable
of expressing more than one antigenic type of P.II simulta-
neously, organisms of the P.IIa-expressing variant were
exposed in sequence to large anti-P.IIe probes, followed by
small anti-P.IIa probes (Fig. 3). Very few cells were double
labeled, and most cells were labeled by the small anti-P.IIa
probe alone. Since this P.IIa phenotype had been chosen for
its expression of a single P.II type, the reduced expression of
P.IIe by cells of this culture, and thus the limited number of
cells marked by two P.II probes, was not surprising.
To increase the expression of antigenic types of P.11 other
than P.IIa, the P.IIa-expressing culture was passaged non-
selectively on five successive days and frozen in defibrinated
sheep blood. This frozen stock was then thawed and plated
on clear typing agar. The organisms from this nonselectively
passaged culture were first examined in single-label experi-
ments to assess the proportion of cells expressing each type
of P.11. The percentage of cells labeled by each anti-P.II
probe increased dramatically in comparison with the earlier
P.IIa-selected culture. Since the greatest number of gono-
cocci in this culture was labeled by the P.IIa probe (-94%)
or the P.IIb/P.IId probe (-34%), these probes were chosen
for use in double-label experiments. The organisms were
exposed to small anti-P.IIa probes, followed by large anti-
P.IIb/P.IId probes. As predicted by the single-label experi-
ments, virtually all of the cells were labeled with anti-P.IIa
probe. One-quarter of these cells were marked with the
anti-P.IIb/P.IId probe as well. Very few cells were marked
by the anti-P.IIb/P.IId probe alone or by neither probe.
Thus, a single gonococcal organism is capable of expressing
more than one P.II antigenic type simultaneously on its
surface.
To determine whether antibody accessibility of the H.8
antigen is affected by differences in P.11 expression, FA1090
P.II phenotype organisms were exposed to a single anti-H.8
probe. No significant differences in anti-H.8 probe labeling
were evident among the gonococcal variants. Each culture
(including the P.1I variant) contained cells which were (-4 to
16%) and were not labeled with the single anti-H.8 probes.
Double-label experiments were then performed with small
anti-P.II probes and large anti-H.8 probes. Within each of
the cultures of P.11 variants, there were gonococci which
were labeled with each probe alone, neither probe, or both
probes (data not shown). Thus, surface expression of P.11
did not preclude or predict surface expression of the neisse-
rial H.8 antigen in strain FA1090.
By using gold immunological probes to examine viable
gonococci, we confirmed, at the level of individual orga-
nisms, some of the predictions based on studies of gono-
coccal colony phenotypes that differ in predominant P.II
expression. The monoclonal antibodies used in this study
bind to variable determinants of the six identified P.II
proteins of strain FA1090 (4, 10). Each of the antibodies
recognized only a single P.11 protein, except for antibody
H.4.1, which binds to both P.IIb and P.IId. The epitopes
recognized by the monoclonal antibodies are not common to
all gonococcal strains, although they are not limited exclu-

































FIG. 2. Variation in the expression of P.IIa on the surface of N. gonorrhoeae FA1O90 (phenotype P.IIa), as detected by gold spheres
complexed with a P.IIa-specific monoclonal antibody. Note the markedly diminished amount of surface labeling by gold probes of several of
the organisms in comparison with adjacent gonococci. Negative stain was used. Magnification, x 24,360.
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FIG. 3. Simultaneous localization of two P.IIs on the surface of N. gonorrhoeae FA1O90, as detected by large anti-P.IIe gold probes,
followed by small anti-P.IIa gold probes. Note the attachment of both sizes of gold probes to the surface of the diplococcus. Thus, a single
gonococcal-n organism cann producei more than one antigenic type of P.11 smimutaneousl.1 Negative- stain was used. Magnification, x 4A4,160
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We found that antigenically variable portions of the P.1I
proteins of FA1090 were exposed on the surfaces of bacteria
and on elaborated outer membrane blebs. Colony pheno-
types that expressed a particular P.II protein always con-
tained a minority population of organisms that was labeled
with probes for the other P.11 proteins. For example, a
variant chosen for predominant expression of P.IIa con-
tained cells (s11%) that were labeled with probes for P.IIb
and P.IId, P.IIc, P.IIe, and P.IIf. The number of gonococci
labeled by the heterologous P.1I probes could be doubled by
nonselective passage over a few days. Thus, preferential
expression of one type of P.II by gonococci in vitro was not
a stable trait. As demonstrated in double-label experiments,
a single gonococcal cell is capable of expressing more than
one type of P.II simultaneously. These results emphasize the
heterogeneity of P.II expression in gonococcal colonies,
which may be a complication in studies attempting to clarify
the functions of different P.II proteins.
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